The physiologic effects of circulating plasma catecholamines may be responsible for the observed clinical and pathologic findings in exercise-induced asthma.
T , he pathophysiologic changes noted in the lungs of human adult subjects during an attack of bronchial asthma has been reported as contraction of smooth muscle in the bronchial tree, edema of the mucous membrane and exudation of a viscid mucus into the bronchial lumen. Other findings noted are passive dilatation of the capillary bed, dilatation of the bronchial lymphatics with increase in lymph flow and an accumulation of inflammatory cells, particularly eosinophils, in the bronchial mucous membrane. These multiple changes are due to either local release in the lung, or to general systemic release with presentation to the lung, of naturally produced compounds collectively termed pharmacologic mediators. The exact relationship of these mediators, such as histamine, serotonin, bradykinin and the physiologically active lipid anions to bronchial asthma has only been briefly examined. Even less consideration appears to have been given to the place of the two catecholamines, norepinephrine ( NE) and epinephrine (E).
The physiologic effects of the catecholamines 1 in an extensive survey, have noted when studied singly and in isolated models, the major effect of norepinephrine is to produce smooth muscle contraction, and although this has been clearly demonstrated in vascular smooth muscle, there is less evidence to indicate that it will produce bronchiolar smooth muscle contraction. Norepinephrine stimulates bronchial mucus gland secretion and may induce mucosal edema. Epinephrine will relax bronchial smooth muscle and this is more evident when the muscle is constricted. Epinephrine is also known to act as a mucosal decongestant. The effects of varying ratios of both catecholamines on the bronchioles have not apparently been recorded. In some asthmatic patients, physical exercise induces an attack of dyspnea with wheezing, and this type of patient appeared to be a useful model to study. The initial physiologic and chemical observations could be made when apparently normal, followed by further observations when provoked to an attack of wheezing of exercise.
This study records the estimation of plasma norepinephrine and epinephrine before and after exercise in patients with asthma and in controls.
MATERIALS AND METHODS
Eleven patients were studied and the only criterion of selection was that the initial forced expiratory volume first second (FE Vi) before exercise should exceed one liter. Of these 11 subjects seven had chronic asthma with a history of breathlessness on exertion, three of which had been on corticosteroids prior to but not on the day of study; three were sporadic asthmatics in remission at the time of study, and one patient had attacks of asthma only after exercise. All patients had prior experience in the exercise laboratory.
On the day of test they attended the laboratory in a fasting state and were then rested in a chair for approximately one half hour. At the end of this time 15 ml of blood from the right antecubital vein was withdrawn into a glass syringe lubricated with heparin. The blood was immediately transferred to a polypropylene tube which contained approximately 30 mg of disodium ethylenediamine tetra-acetate (EDTA). The tube was capped, thoroughly mixed and placed in ice. Within 15 minutes the blood was centrifuged in a refrigerated centrifuge at 2000 X g and 4°C for 20 minutes. This sample was considered the resting catecholamine level. The subjects were then exercised on an electronic cycloergometer to maximum or near maximum levels, as judged by the rise of their heart rate to 150 to 175 beats per minute, or to the limitations of dyspnea. The initial load given was determined by preexercise FEV, and by the sex and age of the patient. The load was increased by 300 Kilopon meters per minute at four minute intervals over a period of approximately 10 to 12 minutes, and the total work load was recorded. Immediately after the cessation of exercise further blood for catecholamine assay was taken by venepuncture from the same anatomic site, and again after ten minutes of rest.
Spirometric measurements of FEV] used to detect airway obstruction were taken before exercise and immediately after cessation of exercise. Minute ventilation during exercise was recorded at exact minute intervals on a dry gas meter, and the heart rate was monitored by electrocardiograph throughout exercise. Arterial blood was drawn for pH and gas tension studies one minute prior to the onset of exercise and at the end of exercise. Eleven nonasthmatic controls carefully matched by age, sex and approximately similar physical condition, all of whom had had prior experience on the cycloergometer were studied after a similar type and duration of exercise. In addition, 11 normal subjects, also of matching age and sex to the asthmatic patients but who had not had prior experience on the cycloergometer, were submitted to identical exercise and blood for catecholamine assay was drawn at the same times.
Plasma catecholamines were measured in duplicate by the method of Griffiths and Leung. 2 The normal range previously established in 50-subjects for the resting fasting condition is 0.24 ng/ml, SD ± 0.09 for norepinephrine and 0.04 ng/ml, SD ± 0.04 for epinephrine.
RESULTS
The data obtained for plasma catecholamines and FEVi in the 11 asthmatic patients is shown in Table 1 . Similar data obtained for the control group with exercise experience is shown in Table 2 , and the control group without exercise experience in Table 3 .
Changes in Norepinephrine during Exercise
The increase of norepinephrine from basal resting values to the end of the graduated exercise in the asthmatic patients and the two control groups was studied by the analysis of variance method using the model
representing the change in norepinephrine as an additive sum of group effect, (where group 1 represents asthmatic subjects, group 2 controls with experience and group 3 controls without experience) and j, individual variation, with 11 subjects in each of the three groups. The hypothesis tested was that no difference existed between the three groups with respect to change in norepinephrine. 
The figures conclude a highly significant difference exists among the three groups and hence reject the null hypothesis. The data for norepinephrine were further examined by Tukey's method of multiple contrasts and applied to compare the mean effects of the three groups in pairs.
The mean effects were At 95 percent confidence level, the change in norepinephrine in the patients with asthma was found to be significantly higher than in either normal group, but no significant difference could be detected between the two normal groups, as shown by the following figures. Even at 90 percent confidence level, the two normal groups showed no significant difference.
Changes in Epinephrine during Exercise
An analogous method was applied to the exercise data studying the rise in epinephrine in the three defined groups, from resting basal values to the end of graduated exercise. ie highly significant difference between groups. Tukey's method was further applied to the epinephrine values comparing the three groups. The mean effects were:
(patient with asthma) yi = 0.1736 (normal with experience) 72 = 0.0322 (normal without experience) ys = 0.1397
At 95 percent confidence level the mean epinephrine effect in the asthmatic groups was shown to be significantly higher than in the normal group with experience. No significant differences could be detected between the asthmatic group and the normal group without experience, nor between the two normal groups, as shown by the following figures: -0.0744 < 71 -ya < 0.1422 0.0331 < y, -y2 < 0.2497 -0.008 < y3 -y2 < 0.2158
At 90 percent confidence level a significant difference could be shown between the two normal groups as well. However, no significant difference could be detected between the asthmatics and the groups without experience.
-0.0598 < yi - 
Correlation of Norepinephrine and Epinephrine in Asthmatic Group
The joint behavior of the changes in norepinephrine and in epinephrine in response to exercise was investigated statistically. The correlation coefficient between A NE and A E was calculated to be ri2 = + 0.7926 which was highly significant (P<0.01) and suggests a significant positive correlation between the two variables. That is, a simultaneous rise in both norepinephrine and epinephrine occurs.
Partial Correlations of Nonrepinephrine, Epinephrine and FEV 1 in the Asthmatic Group
To examine the joint behavior of changes in norepinephrine and in FEVi, the more selective technique of partial correlation coefficients was used (holding the epinephrine variable constant).
The result was
7341 which is a negative quantity and significant (P<0.05) Similarly the partial correlation coefficients relating changes in epinephrine and in FEVi were computed (holding the norepinephrine variable constant).
= +06468 which is a positive quantity and is significant (P<0.05)
The net effect of the norepinephrine increase following exercise in the asthmatic group is to reduce FEVi, whereas the net effect of the epinephrine elevation is to increase FEVi,
DISCUSSION
There is now considerable evidence showing that catecholamine release into the circulating blood follows exercise. Vendsalu 3 estimated venous catecholamines by the tri-hydroxy-indole method in healthy subjects after graduated exercise and showed that the amine concentration in plasma was dependent on the exercise work load. He further noted that the predominant catecholamine released was norepinephrine with only slight or moderate rises in epinephrine. Haggendal and co-workers 4 used a similar sensitive method of catecholamine estimation in arterial blood and found that a total exercise load of 4500 Kilopon meters over ten minutes produced little increase in norepinephrine but above this load there was an appreciable rise proportional to the exercise given. He noted, in contrast to Vendsalu and the present study, no detectable rise in epinephrine at any exercise load. The data of both Vendsalu and Haggendal correlating catecholamine release with the exercise load indicate comparison of the asthmatic must be made to a control similarly exercised. The data presented in this experiment indicate that the asthmatic patients subjected to a mean exercise load of 5800 Kilopon meters over 12 minutes, developed a significantly higher norepinephrine value when compared to both normal groups of controls. The asthmatic patients who had previous exercise experience also showed a significant elevation of epinephrine when compared to the control group with experience but not to the group without experience. This observation noted in the untrained control group demonstrates the effect of exercise familiarization on untrained subjects, indicating why two control groups were used and is similar to data obtained in patients convalescing after myocardial infarction and submitted to an exercise retraining program. 5 The initial epinephrine response to exercise in these patients was similar to the nonexercised controls, but after familiarization with the cycloergometer a reduction in epinephrine values to identical exercise was found. It is concluded from the data presented, that asthmatic subjects submitted to exercise show higher values for both norepinephrine and epinephrine than normal controls similarly exercised. Simple correlation analysis between rises in norepinephrine and epinephrine during exercise suggests a unitary sympatho-adrenal discharge.
Comparison of the changes in FEVi with both catecholamines in the asthmatic group indicate that the net effect of the norepinephrine rise is to reduce the FEVi, whereas the net effect of the epinephrine rise is to increase the FEVi. Other authors 6 have noted reduction of FEV, in exercise-induced asthmatic patients, while Fisher and associates 7 have demonstrated an average increase of airway resistance of 310 percent more than the highest control values in patients with exercise-induced wheezing attacks. They also noted airway resistance could be prevented by the inhalation of 6 percent to 8 percent CO2. The effect of the altered blood and airway gas tensions must therefore be considered, since experimental evidence shows concentration of CO2 in airways from 0 to 5 percent relax bronchiolar smooth muscle, whereas concentration from 10 percent to 30 percent initiate constriction. Severe hypoxia with levels of P02 mm Hg dilates the airway, but less severe hypoxia equivalent to 10 percent O2 has a constrictive effect on denervated lungs in situ? The minor changes in Vco-i and P02 have been reported by Katz and colleagues 9 in children with wheezing induced by exercise after a comparative period of activity. The patients with the more marked elevation of plasma catecholamines were also noted to develop respiratory acidosis. These data are in accord with Nahas and Steinsland 10 who demonstrated in rats an increased catecholamine secretion with respiratory acidosis, and with Euler 11 who noted on isolated ox adrenergic nerve fibers a more rapid release from the catecholamine granules in an acid environment. It is speculative at this stage to consider whether the acidosis was induced by exercise, hence creating a milieu for increased catecholamine secretion, or whether there was initial catecholamine secretion stimulated by exercise with constriction of the sensitized bronchiolar musculature of the asthmatic producing respiratory acidosis.
The increased circulating venous catecholamines in both patients and control subjects reflect a balance between release and removal. In the asthmatic patients altered mechanisms of elimination from the blood normally limited to two or three circulation times, may occur. Absorption into the catecholamine granule, in either adrenal medullary cell or in sympathetic neurone, degradation to less active forms like the metanephrines and 3-methoxy 4-hydroxymandelic acid by enzymatic cleavage, and urinary excretion account for clearance of the circulating catecholamines. The studies of Vane 12 indicate that the lung acts as an important organ of reabsorption for norepinephrine but not epinephrine.
There has been little previous information relating catecholamines to bronchial asthma. Masuda, Notske, and Holmes 13 studied two patients with confirmed bronchial asthma by collecting total daily samples of urine over a 30-day period, and by performing differential analysis of metanephrine and normetanephrine. The results were correlated with attacks of asthma and showed marked elevation of the metabolites, particularly normetanephrine, during these attacks. These findings are at variance with those of Mathe and Knapp, 14 who studied urine catecholamines in six patients with asthma during stress-induced symptomatic phases and found low urine epinephrine levels but normal norepinephrine and 3-methoxy-4-hydroxymandelic levels when compared to a similar number of controls. They interpreted their findings as being caused by a decreased activity of the adrenal medulla in asthmatic subjects but with normal activity of the sympathetic nervous system.
If the catecholamines are the chemical mediators responsible for bronchial obstruction through bronchoconstriction, mucosal edema or mucous obstruction, then it might be expected to find similar changes in other situations where there is a rise of catecholamines. Haggendal 4 noted elevations of norepinephrine as high as 11.2 ng/mg in his series of young fit athletes subjected to prolonged, heavy exercise. In cardiogenic shock following myocardial infarction, elevation of plasma catecholamines to 4.2 ng/ml has been reported. 13 In neither situation was bronchial obstruction similar to that seen in asthma observed. This suggests a further defect must be present in the asthmatic before the pulmonary effects are induced by the high circulating catecholamine concentration. Ahlquist 16 defined the activity of catecholamines in terms of adrenergic receptors, either alpha receptors responding by smooth muscle constriction to epinephrine, then norepinephrine in that order, or beta receptors responding by smooth muscle relaxation and sensitive to epinephrine only. The evidence of alpha receptors within the lung was demonstrated in experiments with guinea pig isolated trachea by Everitt and Cairncross. 17 Confirmation of these findings, not only in guinea pig trachea but in human tracheal and bronchial smooth muscle, has been made by Adolphson, Albern and Townley. 18 Sutherland and co-workers 19 have further clarified the mode of action of catecholamines with the second messenger concept. Activation of membrane located adenyl cyclase by the catecholamines, particularly epinephrine, initiates formation of 3 to 5 cyclic AMP from ATT. The activity of the catecholamines in this respect, however, appears to have been studied individually and not combined in normal physiologic ratios or in abnormal pathologic ones. Although present evidence is not conclusive, Sutherland and associates have considered the alpha receptor effect is mediated through decrease in adenyl cyclase activity.
The data presented in this study suggests increased alpha receptor sensitivity in asthmatic patients. When challenged with increasing concentrations of both circulating catecholamines, an alpha response will occur, resulting in known pathologic changes previously described. In support of this concept of alpha sensitivity, pharmacologic evidence has been presented by Kerr, Govindaraj and Patel 20 indicating that alpha blockers prevent the bronchoconstrictive changes noted in bronchial asthma. In a group of 20 asthmatics whose FEVi dropped significantly after intravenous histamine injection, it was noted that preadministration of the alpha blockers phenoxybenzamine and phentolamine completely abolished the constrictive effects. The mechanism of this drug effect is not known and it must be appreciated that phenoxybenzamine will both increase the rate of norepinephrine release as well as inhibit reuptake into the granule. 21 Phentolamine has similarly been shown to increase circulating catecholamine levels, although by what mechanism is unclear. Conversely Szentivanyi 2 ' 2 has proposed a genetic or acquired block on the beta receptor, leaving alpha stimulation unopposed. In asthmatic subjects, Richardson and Sterling 23 have indicated that the administration of beta adrenergic blockers such as propanolol causes a significant fall in specific airway conductance.
This study suggests that elevation of both catecholamines, norepinephrine and epinephrine may be related to pathophysiologic changes such as FEVi in exercise-induced asthma. However, it is emphasized that only a single aspect of a multifactorial disease has been assessed, and the conclusions drawn are applicable to exercise-induced asthma only. It is feasible to suggest that the high concentration of plasma catecholamines found in the asthmatic merely indicate a response to being unfit in a chronic respiratory disease.
There is considerable biochemical investigation to be performed in all types of bronchial asthma before a final pathway is established.
